The aetiopathogenesis of neuroleptic malignant syndrome (NMS) is thought to be either dopamine depletion or blockage, or a hypermetabolic state in muscle. Sympathoadrenomedullary hyperactivity has been suggested'. Differential diagnosis should entertain the common but severe parkinsonian reactions, the more rare malignant hyperthermia and acute lethal catatonia", The following case is intended to elucidate the occasional iatrogenic nature of NMS and to demonstrate the recovery of the patient without specific medically-accepted treatment",
Case report
A 22-year-old woman was brought to my office on an emergency basis. Three years earlier she had suffered from a mild depressive episode but had since been in good health until she suddenly exhibited confused manic behaviour. She became excited, hyper-religious, meddlesome, insomniac and, at times, depressed and weepy. Thorazine 100 mg three times daily and Valium 5 mg twice daily were prescribed by her attending physician. Subsequently hospitalized, her psychiatrist prescribed Cogentin 1 mg three times daily, Haldol 20 mg four times daily orally, Dalmane 30 mg at bedtime and Prolixin Decanoate 25 mg weekly. Two weeks later, found to be more delusional and suspicious, her Prolixin was doubled to 50 mg.
My examination showed her posture to be stiff and semicatatonic. She moved in short steps. The facies was mask-likeoccasionally frightened. Her voice was whispery. Physical examination revealed: pipe-like rigidity of extremities, especially upper; tremor of hands; dyspnoea; tachycardia; blood pressure standing -90/60, seated -94/60; hypoactive reflexes; temperature 38.3°C; no torsion spasms. Electrocardiogram, chest and skull X-rays were normal. The results oflaboratory analyses may be seen in Table 1 . A diagnosis of iatrogenic NMS, caused by mega-doses of neuroleptics, was made.
Hospitalization, bromocriptine or dantrolene were refused but Valium 5 mg twice daily was accepted for her anxiety. Benzodiazepines '... should be ... considered
[for ] comfort and to decrease the hyperadrenergic state 4. Her neuroleptics were decreased over a period of 4 weeks and eventually discontmued", 
Discussion
NMS can occur at any point in anti-psychotic drug therapy with either high or low potency neuroleptics and also following multiple changes from one neuroleptic to another", Neuroleptic medication should be increased in a step-wise manner until clinical improvement and stabilization of mood are achieved. At times, small doses of neuroleptics are therapeutic and the side effects are minimized. Potkin et al.' state: 'It would seem prudent to consider the possibility that non-response in a patient may be a result of too much medication rather than of not getting enough medication'. That may have been the case in our patient. We could not ascertain whether her previous psychiatrist had checked the blood level of the prescribed neuroleptics. To this effect numerous studies show no statistically significant relationship between haloperidol blood levels and clinical response". This case reminds one of the questionable validity of monitoring the haloperidol blood level and its relationship to a therapeutic clinical response. The concept of a curvilinear therapeutic window, wherein once a peak therapeutic response has been reached further increases in the dosage of medication bring about deterioration of the patient's mental condition and serious side effects while the therapeutic effect gradually diminishes to a minimum, should also be kept in mind 8 ,9 . Levenson stated: 'Most cases of malignant neuroleptic syndrome have appeared after patient received haloperidol or depot-fluphenazine'J''. In this case high doses of haloperidol and depot-fluphenazine had been used together. The reappearance ofNMS following the administration oflithium carbonate has been reported". The importance of a time lapse prior to introducing new neuroleptics of lithium in patients who had previously suffered from NMS has been pointed out",This patient has had no recurrence of her NMS for 3 years. To our knowledge this is the only reported case of a patient on lithium after NMS with such a long follow-up.
In one reported studyl 2 ' ••• fever was unimpressive .. .' CPK ranged from 347 to 4285 Ulml in nine (64%) of the 14 patients in that study and in one patient was normal. Our patient's temperature was 37.5°C and the CPK was 720 Uzml, Laboratory findings of 'severe polymorphonuclear leukocytosis ... attaining 12 000 to 30 OOO/cu.mm .. .' have been reported-t, Our patient's leukocytosis was 13000 cells/mm", This case demonstrates that the clinical observation of the patient's condition is of great usefulness without becoming involved in '... fancy mathematical interpretations of plasma level .. .'8,9. Alcoholic brain damage The first presentation was by Dr Allan Thomson (Greenwich District Hospital) who discussed mechanisms of alcoholic brain damage. Increasing evidence from computerized tomography (CTscanning) and cognitive function testing has shown that a high proportion of alcoholics have evidence of such damage. Many patients show varying degrees of brain shrinkage and this finding has recently received neuropathological confirmation from postmortem examinations which have demonstrated reduced brain weights, enlargement of pericerebral space over the cortex and a reduction in the white matter of the cerebral hemispheres. In addition, recent counting techniques have indicated a reduction of approximately 22% in the number of nerve cells in the superior frontal cortex.
These lesions may be the consequence of the Wernicke-Korsakoff syndrome secondary to thiamine (vitamin B 1 ) deficiency. Such lesions have been demonstrated at postmortem examination in approximately 2% of random brain autopsies, not specifically performed on alcoholics. This could mean that almost one million people in the United Kingdom will have these lesions. Brain damage has also been associated with vitamin B 12 , vitamin B 6 and nicotinic acid deficiency.
Thiamine is a co-factor for a number of enzymes in the brain cells concerned with the production of energy from the oxidation of glucose. The activity of one key enzyme, transketolase is reduced in thiamine deficiency and the enzyme protein (apoenzyme) becomes unstable when deprived of its thiamine diphosphate co-factor. This may impair energyyielding metabolism causing excessive glycolysis and the formation of large amounts of lactic acid which is known to damage nerve cells.
Acetaldehyde formed from alcohol in the liver and transported to the brain or produced in situ may also damage the protein part of the transketolase as a result of adduct formation or from the formation of cytotoxic free radicals. Reduced dietary intake, impaired absorption, and depleted body stores lower thiamine levels with reduced thiamine concentrations in the brain. The apotransketolase deprived of its thiamine co-enzyme may suffer acetaldehyde-mediated damage or spontaneous breakdown. This together with the loss of other thiamine-dependent enzymes, causes an increase in anaerobic glycolysis leading to a fall in intracellular pH which, in turn, reduces the stability of the apoenzyme. A consequent loss of important synthetic processes may reduce the protection against further free radical tissue damage.
Alcoholic muscle disease Professor Timothy Peters (King's College School of Medicine) described the two forms of alcoholic muscle disease, acute and chronic. Acute alcoholic myopathy (rhabdomyolysis) is a relatively rare complication of alcoholic binges and is accompanied by markedly-raised plasma creatine kinase activity, evidence of muscle necrosis and myoglobinuria. The muscles are painful and tender without evidence of a loss of muscle bulk. Histologically, the type-I (slowtwitch, aerobic glycolytic) fibres are chiefly affected, and the biopsy shows myonecrosis, disorganization of the myofibres and an inflammatory cell infiltrate. The syndrome is rare, yet serious, affecting at most 5% of acute admissions for alcoholism. In contrast, chronic alcoholic myopathy is a common finding in chronic abusers, affecting between one half and two-thirds of unselected alcoholics referred for assessment and re-education. Clinically, the disorder affects the proximal muscle groups and is accompanied by muscle wasting with significant weakness in about half the patients. However, in contrast to acute myopathy, there is no muscle tenderness and plasma creatine kinase activities are within the normal range. Histologically, only the type-II (fast-twitch, anaerobic glycolytic) fibres are affected. The fibres show a variable degree of atrophy but there is no myofibre disorganization, myonecrosis nor an inflammatory cell infiltrate. The condition develops gradually during 5-10 years of chronic alcohol abuse, but is completely reversible with 6-12 months abstention.
An animal model of the disorder has been recently established and indicates that enhanced susceptibility to alcohol-induced free radical generation is the basis for the selective type-II fibre damage, as these
